SG Americas Securities’s GenMark Diagnostics, Inc GNMK Stock Holding History

SG Americas Securities’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-47,845	Closed	-$1.14M	–	3432
2021 Q1	$1.14M	Buy	+47,845	New	+$889K	0.01%	1436
2020 Q3	–	Sell	-37,156	Closed	-$547K	–	3776
2020 Q2	$547K	Buy	37,156 +17,107	+85%	+$174K	﹤0.01%	2017
2020 Q1	$83K	Buy	+20,049	New	+$94K	﹤0.01%	3070
2019 Q3	–	Sell	-12,246	Closed	-$79K	–	3335
2019 Q2	$79K	Buy	+12,246	New	+$86.3K	﹤0.01%	2850
2018 Q1	–	Sell	-10,400	Closed	-$43K	–	3661
2017 Q4	$43K	Buy	+10,400	New	+$62.6K	﹤0.01%	2994
2016 Q4	–	Sell	-11,568	Closed	-$137K	–	3587
2016 Q3	$137K	Buy	+11,568	New	+$112K	﹤0.01%	2806

SG Americas Securities's GNMK Position: Q2 2021 in Review

SG Americas Securities sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 47,845 shares — an estimated $1.14M sold.

SG Americas Securities first reported a position in GNMK in Q3 2016 and held it in 6 quarters. The position peaked at $1.14M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

SG Americas Securities reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
SG Americas Securities sold 47,845 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.14M.
SG Americas Securities first reported a position in GenMark Diagnostics, Inc in Q3 2016 and held it in 6 quarters.
SG Americas Securities's GenMark Diagnostics, Inc position peaked at $1.14M in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on SG Americas Securities's 13F filing for Q2 2021, filed 12 Aug 2021.